Pfizer Inc (PFE)
25.39
-0.03
(-0.12%)
USD |
NYSE |
Apr 18, 16:00
25.41
+0.02
(+0.08%)
Pre-Market: 06:39
Pfizer Free Cash Flow (Quarterly): 4.196B for Dec. 31, 2023
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 4.196B |
| September 30, 2023 | 2.646B |
| June 30, 2023 | -2.122B |
| March 31, 2023 | 73.00M |
| December 31, 2022 | 7.581B |
| September 30, 2022 | 5.133B |
| June 30, 2022 | 7.419B |
| March 31, 2022 | 5.898B |
| December 31, 2021 | 4.912B |
| September 30, 2021 | 10.21B |
| June 30, 2021 | 10.76B |
| March 31, 2021 | 3.984B |
| December 31, 2020 | 4.812B |
| September 30, 2020 | 1.583B |
| June 30, 2020 | 3.098B |
| March 31, 2020 | 2.684B |
| December 31, 2019 | 3.591B |
| September 30, 2019 | 3.848B |
| June 30, 2019 | 2.023B |
| March 31, 2019 | 1.08B |
| December 31, 2018 | 4.006B |
| September 30, 2018 | 4.697B |
| June 30, 2018 | 3.423B |
| March 31, 2018 | 1.565B |
| December 31, 2017 | 6.316B |
| Date | Value |
|---|---|
| September 30, 2017 | 4.292B |
| June 30, 2017 | 2.751B |
| March 31, 2017 | 1.226B |
| December 31, 2016 | 5.272B |
| September 30, 2016 | 4.305B |
| June 30, 2016 | 3.109B |
| March 31, 2016 | 1.507B |
| December 31, 2015 | 4.236B |
| September 30, 2015 | 4.695B |
| June 30, 2015 | 3.827B |
| March 31, 2015 | 434.00M |
| December 31, 2014 | 5.203B |
| September 30, 2014 | 3.902B |
| June 30, 2014 | 3.759B |
| March 31, 2014 | 2.637B |
| December 31, 2013 | 5.225B |
| September 30, 2013 | 5.572B |
| June 30, 2013 | 3.447B |
| March 31, 2013 | 1.975B |
| December 31, 2012 | 4.362B |
| September 30, 2012 | 4.718B |
| June 30, 2012 | 3.727B |
| March 31, 2012 | 2.52B |
| December 31, 2011 | 4.441B |
| September 30, 2011 | 3.985B |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-2.122B
Minimum
Jun 2023
10.76B
Maximum
Jun 2021
4.333B
Average
3.984B
Median
Mar 2021
Free Cash Flow (Quarterly) Benchmarks
| Amgen Inc | 289.00M |
| Gilead Sciences Inc | 1.954B |
| Johnson & Johnson | 5.804B |
| Viking Therapeutics Inc | -17.64M |
| Moderna Inc | 402.00M |